Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00109083 · ClinicalTrials.gov registry record · Phase 2

A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine

A Phase 2 study of Migraine Headaches, sponsored by SK Life Science.

Completed
Registry status
Phase 2
Development phase
300
Enrollment target
20
Study locations

NCT00109083 is a Phase 2 study of Migraine Headaches that has completed, run by SK Life Science. The registered enrollment target is 300 participants, above the 61-participant average among 4 other Migraine Headaches trials with a reported enrollment target (392% higher). The trial reports 20 study locations across 16 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00109083, a Phase 2 study of Migraine Headaches, has completed, sponsored by SK Life Science.

COMPLETED
Registry status
Phase 2
Development phase
300 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to evaluate whether RWJ-333369 is a safe and effective treatment in reducing the number of migraine headaches when added to a person's usual medications for acute migraine headache relief.

Conditions Studied

Migraine Headaches

Interventions

  • DRUG RWJ-333369

Study Locations (20)

Florida

  • - Miami
  • - St. Petersburg

Massachusetts

  • - Brockton
  • - Springfield

Ohio

  • - Cincinnati
  • - Mogadore

Texas

  • - Austin
  • - Houston

Alabama

  • - Northport

Arizona

  • - Phoenix

Arkansas

  • - Little Rock

California

  • - Berkeley

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2002-03
Est. Completion 2006-02
Phase Phase 2

Sponsor

SK Life Science

25 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00109083

The ClinicalTrials.gov registry entry for NCT00109083 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 61-participant average among 4 other Migraine Headaches trials with a reported enrollment target (392% higher). The listed sponsor is SK Life Science, which has 25 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Migraine Headaches appearing as the primary indexed condition, and to 1 intervention - of which RWJ-333369 is the first listed.

NCT00109083 reports 20 study locations spanning 16 distinct geographic areas - top geographies include Florida, Massachusetts, Ohio.

Frequently Asked Questions

What is clinical trial NCT00109083 about?

NCT00109083 is a clinical study titled "A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine". The purpose of this study is to evaluate whether RWJ-333369 is a safe and effective treatment in reducing the number of migraine headaches when added to a person's usual medications for acute migraine headache relief.

What is the current status of trial NCT00109083?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2002-03. Estimated completion is 2006-02.

What conditions does trial NCT00109083 study?

This clinical trial studies the following conditions: Migraine Headaches.

What interventions are being tested in trial NCT00109083?

The interventions under investigation include: RWJ-333369 (DRUG).

Who is sponsoring clinical trial NCT00109083?

This trial is sponsored by SK Life Science, which has 25 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00109083 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Migraine Headaches

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Migraine Headaches

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.